The Scotts Miracle-Gro Company
SMG
$62.91
+1.37%
The Scotts Miracle-Gro Company is the largest purveyor of home lawn and gardening products in the United States, offering a broad range of well-recognized brands including Scotts, Miracle-Gro, Roundup, Ortho, and Tomcat. The company operates primarily in the Agricultural Inputs industry, with its US consumer segment generating the vast majority of revenue and profits, and a significant portion of sales coming from Home Depot and Lowe's. Currently, the stock is attracting investor attention due to its strategic divestiture of the Hawthorne Gardening Company, which signals a refocus on core consumer lawn and garden operations, alongside a recent earnings beat that has driven a sharp price rally. The market is debating whether this refocusing and margin improvement can sustain long-term growth and justify the stock's recent valuation re-rating.…
SMG
The Scotts Miracle-Gro Company
$62.91
Related headlines
Investment Opinion: Should I buy SMG Today?
Based on the analysis, SMG is rated a 'Buy' with a thesis that the strategic refocus on core consumer lawn and garden products, combined with margin expansion and a discounted forward valuation, will drive earnings growth and stock appreciation. The consensus analyst rating is 'Buy' with an average target price of $77.00, implying 13.0% upside from the current price of $68.16. This rating is supported by the company's Q2 2026 revenue growth of 2.7% YoY, gross margin improvement to 41.8%, and a forward PE of 14.3x versus the industry average of 22.0x, suggesting the stock is undervalued relative to its growth prospects. Additionally, the company generates positive free cash flow of $379.7 million TTM, providing a cushion for debt reduction and dividend payments.
Sign up to view all
SMG 12-Month Price Forecast
The AI assessment is bullish with medium confidence, driven by the attractive forward valuation, improving margins, and positive analyst sentiment. However, the high leverage and customer concentration introduce significant risks that could derail the thesis. The stance would be upgraded to high confidence if the company delivers on its EPS estimates and reduces debt, while a downgrade to neutral would occur if revenue growth stalls or margins compress. Overall, the risk-reward is skewed to the upside, but investors should monitor the company's ability to execute its turnaround.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on The Scotts Miracle-Gro Company's 12-month outlook, with a consensus price target around $77.17 and implied upside of +22.7% versus the current price.
Average Target
$77.17
0 analysts
Implied Upside
+22.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$70 - $82
Analyst target range
Analyst coverage is moderate, with 6 analysts providing ratings, and the consensus recommendation is 'Buy' with a mean rating of 2.0 (where 1 is Strong Buy and 5 is Sell). The average target price is $77.00, implying an upside of 13.0% from the current price of $68.16. The target range spans from $70.00 to $82.00, with the low target representing a modest 2.7% upside and the high target a 20.3% upside. The relatively narrow spread of $12.00 suggests a moderate level of conviction among analysts. Recent ratings actions have been mostly positive, with Wells Fargo reiterating Overweight in July 2026, Stifel maintaining Buy, and Jefferies upgrading to Buy in November 2025, though JP Morgan downgraded to Neutral in March 2026. The consensus leans bullish, reflecting optimism about the company's strategic refocus and earnings recovery, but the wide range indicates uncertainty about the pace of growth.
Bulls vs Bears: SMG Investment Factors
SMG presents a mixed picture: the strategic refocus on its core consumer business, strong Q2 results, and attractive forward valuation are compelling bull arguments, while high leverage, customer concentration, and persistent underperformance are significant bear concerns. Currently, the bull case has stronger evidence, given the earnings beat and margin expansion, but the debate hinges on whether the company can sustain its recovery and reduce debt. The most critical tension is whether the forward PE of 14.3x is justified by achievable earnings growth, or if the market is overestimating the pace of improvement. If SMG delivers on its EPS estimates of $7.86 for the year, the stock could re-rate higher, but any miss would expose the stock to downside given its high beta and leverage.
Bullish
- Strategic refocus on core business: The divestiture of Hawthorne Gardening Company to Vireo Growth Inc. signals a clear strategic pivot back to the highly profitable US consumer lawn and garden segment, which generated 94.4% of Q2 2026 revenue. This refocusing should improve operational efficiency and margin stability, as the company sheds a historically volatile and capital-intensive business.
- Strong Q2 earnings beat: Q2 2026 revenue grew 2.7% YoY to $1.4595 billion, while gross margin expanded to 41.8% from 38.6% a year ago, and net income swung to $238.6 million from a loss in the prior quarter. This demonstrates robust operational leverage and the success of cost-saving initiatives, which are likely to drive further earnings growth.
- Attractive forward valuation: The forward PE of 14.3x is a 35% discount to the industry average of 22.0x, while the trailing PE of 22.6x is roughly in line. This suggests the market is pricing in significant earnings growth that may not yet be fully reflected, offering upside if the company delivers on its recovery trajectory.
- Positive analyst sentiment: The consensus rating is 'Buy' with a mean score of 2.0, and the average target price of $77.00 implies 13.0% upside from the current price of $68.16. Recent actions include Wells Fargo reiterating Overweight and Jefferies upgrading to Buy, indicating growing confidence in the company's turnaround.
Bearish
- High leverage and negative equity: The debt-to-equity ratio is -6.66, reflecting negative shareholders' equity due to years of losses and buybacks. This financial structure increases bankruptcy risk and limits financial flexibility, making the company vulnerable to rising interest rates or a downturn in consumer spending.
- Revenue concentration in two retailers: Over half of revenue comes from Home Depot and Lowe's, creating significant customer concentration risk. Any loss of shelf space, pricing pressure, or a slowdown at these retailers could disproportionately impact SMG's sales, as evidenced by the 2.7% revenue growth in Q2 2026, which is modest.
- Underperformance vs. market: The stock is up 10.2% over the past year, but the S&P 500 gained 21.9%, resulting in a relative strength of -11.7%. This underperformance suggests persistent investor skepticism about the company's growth prospects and could limit multiple expansion.
- High beta and volatility: With a beta of 1.829, SMG is significantly more volatile than the market, amplifying downside risk during market selloffs. The stock's 1-month decline of -1.0% and 3-month volatility (with a max drawdown of -25.26%) highlight the risk of sharp price swings.
SMG Technical Analysis
The stock is in a clear recovery phase, having rebounded from a 52-week low of $52.00 to a current price of $68.16, representing a 31.1% gain from the low. Over the past year, the stock is up 10.2%, but it has significantly underperformed the S&P 500, which gained 21.9% over the same period. The current price sits at 90.5% of the 52-week range (between $52.00 and $75.34), indicating that the stock is trading near the upper end of its yearly range, suggesting strong momentum but also potential overextension. The 1-year relative strength of -11.7% highlights the stock's lagging performance versus the market, though the recent surge has narrowed this gap.
Beta
1.83
1.83x market volatility
Max Drawdown
-25.3%
Largest decline past year
52-Week Range
$52-$75
Price range past year
Annual Return
+4.9%
Cumulative gain past year
| Period | SMG Return | S&P 500 |
|---|---|---|
| 1m | -3.5% | +2.4% |
| 3m | +3.0% | +4.6% |
| 6m | -5.2% | +11.7% |
| 1y | +4.9% | +21.4% |
| ytd | +5.9% | +13.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SMG Fundamental Analysis
Revenue for the most recent quarter (Q2 2026) was $1.4595 billion, a 2.7% year-over-year increase, with the US Consumer segment contributing $1.377 billion, or 94.4% of total revenue. This growth marks a recovery from the prior quarter's decline, as Q1 2026 revenue was $354.4 million, down from $416.8 million in Q1 2025, reflecting the seasonal nature of the business. The company's gross margin improved to 41.8% in Q2 2026, up from 38.6% in the year-ago quarter, driven by cost savings and product mix. Net income for Q2 2026 was $238.6 million, a significant turnaround from the net loss of $125.0 million in Q1 2026, and the net margin expanded to 16.3% from -35.3% in the prior quarter. The company's profitability is highly seasonal, with strong performance in the spring and summer quarters, but the recent quarter's results demonstrate robust operational leverage.
Quarterly Revenue
$1.5B
2026-03
Revenue YoY Growth
+2.7%
YoY Comparison
Gross Margin
41.8%
Latest Quarter
Free Cash Flow
$379699999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SMG Overvalued?
Given that trailing twelve-month net income is positive (EPS of $0.04), the PE ratio is the primary valuation metric. The trailing PE is 22.6x, while the forward PE is 14.3x, indicating that the market expects significant earnings growth in the coming year. This gap of 8.3x suggests that analysts anticipate a substantial improvement in profitability, likely driven by the divestiture of Hawthorne and continued margin expansion. Compared to the industry average PE of 22.0x (based on available data), SMG's trailing PE is roughly in line, but the forward PE is at a 35% discount, implying that the stock is undervalued relative to its growth prospects. Historically, the stock's PE has ranged from negative to over 20x, with the current trailing PE near the higher end of its recent range, but the forward PE is at the lower end, suggesting that the market is pricing in a recovery that may not fully materialize.
PE
22.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 4x~12x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are substantial: SMG carries a negative equity position (debt-to-equity of -6.66), indicating that liabilities exceed assets, which raises solvency concerns. The company's interest expense of $31.3 million in Q2 2026 is a significant burden, and with a payout ratio of 106.3%, it is paying out more than it earns in dividends, which is unsustainable. Additionally, the company's reliance on seasonal quarters means that a weak spring could lead to cash flow shortfalls, as evidenced by the Q1 2026 net loss of $125.0 million. The high beta of 1.829 amplifies these risks, as the stock is more sensitive to market downturns, and the recent 1-month decline of -1.0% shows that even positive news can be overshadowed by macro concerns.
FAQ
The key risks of holding SMG are: (1) financial risk from high leverage, with a debt-to-equity ratio of -6.66 and negative equity, which could lead to solvency issues if earnings deteriorate; (2) customer concentration risk, as over 50% of revenue comes from Home Depot and Lowe's, making the company vulnerable to losing shelf space or facing pricing pressure; (3) market risk from a high beta of 1.829, which amplifies downside during market selloffs; and (4) company-specific risks such as seasonal earnings volatility, with losses in Q1 and Q4, and potential litigation related to Roundup. The most severe risk is a combination of these factors leading to a decline to the 52-week low of $52.00, a -23.7% drop from the current price.
The SMG stock forecast for the next 12 months is moderately bullish, with a base case probability of 50% and a target range of $70-$77, aligning with the analyst average target of $77.00. The bull case, with a 30% probability, targets $75-$82, driven by successful execution of the strategic refocus and margin expansion. The bear case, with a 20% probability, targets $52-$60, reflecting potential setbacks such as a weak spring season or loss of retail distribution. The most likely scenario is the base case, assuming the company meets its EPS estimates of $7.86 and maintains gross margins around 40%. Investors should monitor quarterly earnings and debt reduction progress to gauge which scenario is unfolding.
SMG is undervalued based on forward earnings, with a forward PE of 14.3x versus the industry average of 22.0x, representing a 35% discount. The trailing PE of 22.6x is in line with the industry, but the market is pricing in significant earnings growth, as evidenced by the wide gap between trailing and forward PE. The PS ratio of 0.96x is below the industry average, and the EV-to-EBITDA of 13.2x is reasonable. However, the negative equity and high debt levels complicate the valuation, and the market may be discounting the stock due to these risks. Overall, the stock appears undervalued relative to its growth prospects, but the high leverage warrants a cautious approach.
SMG is a good buy for investors with a higher risk tolerance who believe in the company's turnaround story. The stock offers a 13.0% upside to the average analyst target of $77.00, and the forward PE of 14.3x is a 35% discount to the industry average, suggesting undervaluation. However, the high leverage (debt-to-equity of -6.66) and customer concentration (over 50% from Home Depot and Lowe's) are significant risks. If the company delivers on its EPS estimates of $7.86 and reduces debt, the stock could re-rate higher, but a miss could lead to a decline to the 52-week low of $52.00. Therefore, it is a good buy for those who can withstand volatility and have a 12-month investment horizon.
SMG is more suitable for long-term investment, given its turnaround nature and seasonal earnings volatility. The stock has a beta of 1.829, making it highly volatile in the short term, and the 1-month return of -1.0% illustrates this unpredictability. However, the company's strategic refocus and discounted forward valuation (14.3x PE) suggest potential for long-term appreciation if the turnaround succeeds. The dividend yield of 4.7% provides some income, but the payout ratio of 106.3% indicates the dividend is at risk. A minimum holding period of 12-18 months is recommended to allow the company to execute its strategy and for the market to recognize the value. Short-term traders may find opportunities in the seasonal patterns, but the high volatility and leverage make it a risky short-term play.